Immunotech Laboratories
IMMB · OTC
About IMMB
- Employees
- 4
- Headquarters
- Glendale, California
- Listed
- Jan 7, 2002
- Sector
- Health Care
- Industry
- Biotechnology
- Website
- immunotechlab.com
IMMB key statistics
- Market cap
- 114.99K
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 35.11K
- Volume
- 200
- Open price
- $0.0002
- High today
- $0.0002
- Low today
- $0.0002
- 52 Week high
- $0.0002
- 52 Week low
- $0.0001
Immunotech Laboratories (IMMB) at a glance
Immunotech Laboratories (IMMB) last traded at $0.0002, with a market cap of 114.99K and a price-to-earnings ratio of 0.00.
Volume so far is 200 shares, below the average of 35.11K shares a day.
Over the past year Immunotech Laboratories has ranged from $0.0001 to $0.0002, and now sits 100% of the way up that range.
Similar companies
Companies in the same industry as Immunotech Laboratories
Most active stocks
Highest trading volume today
- SHFSSHF Holdings$0.0899−4.36%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- RBNERobin Energy$0.3978−23.65%
- SDSTStardust Power$0.02−23.66%
- OLOXOlenox Industries$0.737+5.18%
- RCTRedCloud Holdings$0.084+1.94%
- WFFWF Holding$0.0929−3.83%
- AHTAshford Hospitality Trust$1.79−2.72%
- SPCXSpace Exploration Technologies$147.79−0.11%
- NIVFNewGenIvf Group$0.2499−11.73%
- NWGLCL Workshop Group$0.1522+27.90%
- DKIDarkiris$0.0479−6.08%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.